// App-Quantinova.ai

16759 : In-Hospital Outcomes of Coronary Artery Bypass Grafting Candidates Undergoing Percutaneous Coronary Intervention During the Intensive Care Unit Restricted Covid-19 Pandemic: The Multi-Centre Prospective UK-REVASC Registry

Researchers

Presenter

  • Thomas A Kite

Principal Investigators

  • Alexander Chase

  • Abdul Mozid

  • Helen Routledge

  • Stephen P Hoole

  • Nick Palmer

  • Mohaned Egred

  • Divaka Perera

  • Mouyis Kyriacos

  • Manas Sinha

  • Tom Cahill

  • Luciano Candilio

  • Brijesh Anantharam

  • Aengus Murphy

  • Fath-Ordoubadi Farzin

  • Paul Das

  • Paul Morris

  • Nick Curzen

  • Diana Gorog

  • Angela Hoye

  • Sharon Kean

  • Peter Ludman

  • Gregg W Stone

  • Colin Berry

  • Anthony H Gershlick

Medical Centers

  • Univ Hosp of Leicester, Leicester LE QP, United Kingdom

  • Royal Hospitals, Belfast, United Kingdom

  • Singleton Hospital, Swansea, United Kingdom

  • Leeds General Infirmary, Leeds, United Kingdom

  • Worcester Royal Hospital, Worcester, United Kingdom

  • Papworth Hosp, Cambridge

  • Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.

  • Freeman Hosp, Newcastle, Newcastle, United Kingdom

  • Kings College London, London, United Kingdom

  • Barts Heart Centre, London, United Kingdom

  • Salisbury Hosp, Salisbury, United Kingdom

  • Stroke, Oxford Univ Hosps, Oxford, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • Queen Alexandra Hospital, Portsmouth, United Kingdom

  • Univ Hosp Monklands, Airdrie, United Kingdom

  • Manchester Heart Centre, Mancheter, United Kingdom

  • North Wales Cardiac Cntr, Rhyl, United Kingdom

  • University of Sheffield, Sheffield, United Kingdom

  • University of Southampton, Southampten, United Kingdom

  • Imperial College, London, UK

  • Castle Hill Hospital, Driffield, United Kingdom

  • Univ of Glasgow Clinical Trials Unit, Glasgow, United Kingdom

  • Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Mount Sinai, New York, NY

  • Univ of Glasgow, Glasgow

  • Univ Hosp of Leicester, Leicester LE QP, United Kingdom

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Desirudin

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved